Related Experiment Videos
[Pathogenesis and treatment of primary closed-angle glaucoma]
1Clinique ophtalmologique universitaire de Zurich.
Klinische Monatsblatter Fur Augenheilkunde
|May 1, 1992
Summary
Primary angle-closure glaucoma, less common than open-angle glaucoma, results from pupillary block. Treatment involves reducing posterior chamber pressure with hyperosmotic agents, followed by mild miotics to normalize intraocular pressure.
Area of Science:
- Ophthalmology
- Glaucoma Research
Context:
- Primary angle-closure glaucoma (PACG) is less common than primary open-angle glaucoma, occurring in approximately 1/1000 individuals.
- PACG pathogenesis frequently involves pupillary block, stemming from anatomical factors or anterior chamber changes.
- Pupillary block elevates posterior chamber pressure, causing iris displacement and subsequent angle closure.
Purpose:
- To outline the pathogenesis of primary angle-closure glaucoma.
- To describe the recommended treatment strategy for acute angle-closure glaucoma attacks.
- To propose therapeutic guidelines for various clinical scenarios in PACG.
Summary:
- Treatment for PACG focuses on reducing posterior chamber pressure using hyperosmotic agents (e.g., glycerin, mannitol).
- Following pressure reduction, mild miotics are administered to prevent further angle narrowing without causing significant miosis or anterior chamber flattening.
- This approach can normalize intraocular pressure within approximately one hour during acute attacks.
Impact:
- Provides a clear understanding of PACG etiology and management.
- Offers practical therapeutic guidelines for ophthalmologists treating angle-closure glaucoma.
- Aims to improve patient outcomes by standardizing effective treatment protocols.